Cambridge UK, 2nd January 2015 – Bactevo, the Industrial Biotechnology company, is pleased to announce its expansion into the pharmaceutical therapeutics market. This expansion means that the company’s powerful TarGET platform will now be used both to create new medicines in key disease areas of unmet need as well as continuing to develop high value […]
Cambridge UK, December 10th 2014 – Bactevo, the Industrial Biotechnology company, announced today that it has raised additional financing from New Wave Ventures LLP. The financing puts the company in an excellent position for ongoing and future commercial discussions. Bactevo is a Cambridge UK-based company utilising its proprietary molecular engineering technologies, known as TarGET, to […]
Cambridge UK, 12th December 2012- Bactevo has spun-off from the antibiotics discovery company Discuva to develop its core technology expertise in the Industrial Biotechnology sector. Bactevo is a Cambridge UK-based company utilising its proprietary molecular engineering technologies, known as TarGET, to enable the use of bacteria for the synthesis of chemicals from sustainable resources. With […]